The Relationship of Forward and Backward Walking With Selective Motor Control, Trunk Control and Balance in Children With Cerebral Palsy

Sponsor
Alanya Alaaddin Keykubat University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05962749
Collaborator
(none)
25
5.3

Study Details

Study Description

Brief Summary

Cerebral palsy (CP) is defined as a disorder of the developing brain that causes movement disorders and may be associated with other neurologically based disorders. Gait abnormalities are a direct result of damage to the motor areas of the brain and include symptoms such as spasticity, dystonia, weakness, loss of selective muscle control, dependence on primitive reflexes, abnormal muscle and inadequate balance reactions.

Walking backwards during activities of daily living is as important as walking forward. Some of these activities are stepping back towards the chair, stepping back when opening the door and pulling the door, reflexively leaning back when suddenly encountering an obstacle or uneven ground. In addition, backward walking is defined as a more complex activity that requires more neuromuscular control, proprioception sense, and protective reflex activation than forward walking.

Selective motor control is an essential part of typical human movement, allowing for smooth and discrete control of joint movement. Impaired selective motor control causes abnormal reciprocal muscle activations or involuntary combined movements, leading to difficulties with coordination, balance, walking efficiency, and symmetry. Impaired selective motor control is associated with poor gross motor function and balance control, severe general gait deviations, and decreased walking speed.

The aim of this study is to examine the relationship between forward and backward walking and selective motor control, trunk control and balance in children with cerebral palsy.

Condition or Disease Intervention/Treatment Phase
  • Other: Assessment

Study Design

Study Type:
Observational
Anticipated Enrollment :
25 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
The Relationship of Forward and Backward Walking With Selective Motor Control, Trunk Control and Balance in Children With Cerebral Palsy
Anticipated Study Start Date :
Jul 20, 2023
Anticipated Primary Completion Date :
Dec 29, 2023
Anticipated Study Completion Date :
Dec 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Children With Cerebral Palsy

Other: Assessment
3 meter backward walk test (3MBWT), 10 meter walk test (10MWT), Selective Control Assessment of the Lower Extremities (SCALE), Trunk Control Measurement Scale (TCMS), Pediatric Balance Scale (PBS), Functional Independence Measure for Children (WeeFIM), Modified Ashworth Scale (MAS)

Outcome Measures

Primary Outcome Measures

  1. 3 meter backward walk test (3MBWT) [First day]

  2. 10 meter walk test (10MWT) [First day]

Secondary Outcome Measures

  1. Selective Control Assessment of the Lower Extremities (SCALE) [First day]

  2. Trunk Control Measurement Scale (TCMS) [First day]

  3. Pediatric Balance Scale (PBS) [First day]

  4. Functional Independence Measure for Children (WeeFIM) [First day]

  5. Modified Ashworth Scale (MAS) [First day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • To be diagnosed with cerebral palsy by a specialist physician

  • Gross Motor Function Classification System (GMFCS) level I or II

  • Children with lower extremity muscles level ≤ 2 according to the Modified Ashworth Scale (MAS)

  • Ability to follow verbal commands

  • Modified Ashworth Scale (MAS) Level ≤2

  • Complete passive range of motion in the ankle and knee joints

  • Agree to participate in the study (with parent and child consent)

Exclusion Criteria:
  • Having had Botox (Botulinum toxin) or a surgical operation in the last 6 months

  • Having contractures in the ankle and knee joints that affect walking

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Alanya Alaaddin Keykubat University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ebru Keklikci, Research Assistant, Alanya Alaaddin Keykubat University
ClinicalTrials.gov Identifier:
NCT05962749
Other Study ID Numbers:
  • 2023-743
First Posted:
Jul 27, 2023
Last Update Posted:
Jul 27, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ebru Keklikci, Research Assistant, Alanya Alaaddin Keykubat University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 27, 2023